For more than 30 years, Alcimed has been supporting the leaders of the biotechnology sector in their innovation and new market development projects.
Our activities for biotech players
The explorers of Alcimed’s healthcare team support everyday biotech players in a large variety of challenges in their sector: bioproduction, DTx, rare diseases, time-to-market, partnerships, artificial intelligence, market access, and more.
They trust us
Some examples of projects carried out for our clients
Our projects cover diverse subjects such as new therapeutic technologies and approaches, commercial R&D strategies, comprehension of disease treatment and care pathways, market opportunity and licensing evaluations, developing business plans and roadmaps, market access, regulatory evolution, partner search, and many more!
Business development strategy
Generation gene therapy platform based on future disruptive technologies
Identifying partners in the field of immunology and infectious diseases
Assessment of antibodies for a novel oncobiologics platform
State of the art in biological fluid separations and the associated new business opportunities
Development of a standardized tool for portfolio evaluation in oncology and infectious diseases
Future upscaling of manufacturing capabilities of a biotech company
Dual branding strategy and partner evaluation for an innovative multi-indication compound
Novel manufacturing methods in gene therapy
Learn more about our missions and expertise
Clients & Patients
Environment & Climate
Beauty & Nutrition
Energy & mobility
Tech & data
What they say
"The benefit that really Alcimed brought to the table was to have an expert intermediary to take us through the process to really challenge our thinking."
Senior VP and Chief Commercial Officer
"A friendly and efficient team!"
"We recently worked with Alcimed to support us in one of our projects. A project well carried out, with a friendly and efficient team, which respects the timings!"
Marketing Director France
"Alcimed played a decisive role in the selection of the CIL'LICO consortium project."
"By bringing together multiple interests, streamlining the pace of effort for each stakeholder, and coordinating different viewpoints, Alcimed played a decisive role in the selection of the CIL'LICO consortium project, winner of the RHU (University Hospital Research Program) wave 3 competition."
CEO and Co-Founder
You have a project?
Join our adventure
Embark on our adventure and join a team of 220 explorers from over 20 different nationalities with degrees from the best international universities, passionate about scientific breakthroughs, technological innovations, international development, and challenges in healthcare and climate.
To go further
The Belgian biotech scene: 3 reasons why Belgium is a biotech powerhouse
Belgian biotech companies account for 16% of Europe’s biotech turnover. What are the three major building blocks of this Belgian success story?
Molecular pharming: how plant-based pharmaceuticals can revolutionize drug development and manufacturing?
What are the benefits of molecular pharming? Why can plant-based pharmaceuticals be interesting pharmaceutical alternatives? Alcimed explored the potential of molecular pharming to revolutionize drug ...
Long-read sequencing: mechanisms, promises and applications in Healthcare
How do the 2 main technologies on the market work? What are the promising applications in the study of cancers and viral genomes?